MARGARET LEWIS: Open Payments
NPI 1740991389 · MALVERN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,420 in 160 payments from 20 companies in 2025. Trend: 2023 $1,079 · 2024 $2,794 · 2025 $3,420
Food & beverage: $3,321Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $578 |
| ABBVIE INC. | 22 | $520 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $436 |
| Ardelyx, Inc. | 12 | $340 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $252 |
| Madrigal Pharmaceuticals | 12 | $199 |
| QOL Medical, LLC | 12 | $168 |
| PFIZER INC. | 9 | $141 |
| Aimmune Therapeutics, Inc. | 6 | $141 |
| GENZYME CORPORATION | 6 | $122 |
Products named: TREMFYA, ENTYVIO, IBSRELA, RINVOQ, XIFAXAN, DUPIXENT, REZDIFFRA, Sucraid.
Industry payments across PA — which companies pay providers there.
